CG Oncology (CGON) Profit After Tax (2023 - 2026)
CG Oncology (CGON) posted Profit After Tax of -$60.2 million for Q1 2026, down 45.72% on a QoQ basis from -$41.3 million in Q4 2025, and down 74.74% year-over-year from -$238.3 million in Q1 2025.
CG Oncology (CGON) Profit After Tax (2023 - 2026) Analysis & Trends
CG Oncology's Profit After Tax history runs 4 years deep, the most recent figure standing at -$60.2 million for Q1 2026.
- Quarterly Profit After Tax fell 74.74% year-over-year to -$60.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$186.8 million (down 76.92% YoY) and the FY2025 annual result came in at -$161.0 million, down 82.87% from the prior year.
- Profit After Tax was -$60.2 million for Q1 2026 at CG Oncology, down from -$41.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$8.7 million in Q1 2023 and bottomed at -$60.2 million in Q1 2026.
- A 4-year average of -$27.5 million and a median of -$20.4 million in 2024 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 29.93% in 2025, while the deepest fall reached 119.16% in 2025.
- CG Oncology's Profit After Tax stood at -$16.6 million in 2023, then sank by 92.07% to -$31.8 million in 2024, then slipped by 29.93% to -$41.3 million in 2025, then sank by 45.72% to -$60.2 million in 2026.
- Business Quant data shows CGON's Profit After Tax at -$60.2 million in Q1 2026, -$41.3 million in Q4 2025, and -$43.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | CG Oncology | 5.86 Bn | 5.86 Bn | -1.88 Mn | -60.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.20 Mn |
| Dec 31, 2025 | -41.31 Mn |
| Sep 30, 2025 | -43.81 Mn |
| Jun 30, 2025 | -41.43 Mn |
| Mar 31, 2025 | -34.45 Mn |
| Dec 31, 2024 | -31.80 Mn |
| Sep 30, 2024 | -20.41 Mn |
| Jun 30, 2024 | -18.90 Mn |
| Mar 31, 2024 | -16.93 Mn |
| Dec 31, 2023 | -16.56 Mn |
| Sep 30, 2023 | -11.77 Mn |
| Jun 30, 2023 | -11.61 Mn |
| Mar 31, 2023 | -8.67 Mn |